Co-Founder, Dr. Noa Shelach, to Continue with Lutris Pharma as Chief Operating Officer in Newly Established Role TEL AVIV, Israel, April 29, 2025 /PRNewswire/ -- Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous dose...
Lutris Pharma Announces the Appointment of Seasoned Life Science Executive, Sumant Ramachandra, M.D., Ph.D., as Chief Executive Officer
Seeking Alpha / 17 hours ago 1 Views
Comments